Clinical Research Directory
Browse clinical research sites, groups, and studies.
Ectoin Lozenges (EHT02) in the Treatment of Oropharyngeal Allergic Symptoms
Sponsor: Bitop AG
Summary
The goal of this multicentric, prospective, randomised, controlled study (§23b German Act on Medical Devices (MPG)) is to investigate the efficacy of Ectoin Lozenges (EHT02) in treatment and prevention of oropharyngeal allergic symptoms.
Official title: Application of Ectoin Lozenges (EHT02) in Patients With Oropharyngeal Allergic Symptoms
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
90
Start Date
2019-02-04
Completion Date
2019-09-12
Last Updated
2026-10-20
Healthy Volunteers
No
Conditions
Interventions
Medical Device: Ectoin Lozenge
Application of Ectoin Lozenge (EHT02) in accordance with the instructions for use
Locations (8)
Facharzt f. HNO-Heilkunde
Aachen, Germany
Fachärztin für Hals-Nasen-Ohrenheilkunde
Bad Schörnborn, Germany
Facharzt f. Dermatologie ruhrDerm GbR
Bochum, Germany
Facharzt für Lungen- und Bronchialheilkunde
Bonn, Germany
Facharzt für Haut und Geschlechtskrankheiten
Gelsenkirchen, Germany
Arzt für Hals-Nasen-Ohrenheilkunde, Allergologie, Umweltmedizin, Naturheilverfahren, Flugmedizin, Taucherarzt (GTÜM)
Heidelberg, Germany
Fachärztin f. HNO-Heilkunde, Allergologie
Jülich, Germany
Facharzt für Hals-Nasen-Ohrenheilkunde, Allergo GmbH Stuttgart, Klinische Prüfstelle Schorndorf
Schorndorf, Germany